|
|
|
|
Vol. 55, Issue 6, 1011-1019, June 1999
-Aminobutyric Acid Type A Receptors
Department of Molecular Pharmacology and Biological Chemistry,
Northwestern University Medical School, Chicago, Illinois
The n-octanol effects on the
-aminobutyric acid
type A (GABAA) receptor were studied in human
embryonic kidney 293 cells transfected with
1,
2, and
2S
subunit cDNAs. GABA-evoked currents had an EC50 of
13.3 ± 1.7 µM and a Hill coefficient (nH) of
1.4 ± 0.1. n-Octanol was also capable of evoking a
small current with an EC50 of 1000 µM and an
nH of 2. In addition, n-octanol modulated GABA-induced currents in a concentration-dependent manner.
Coapplications of n-octanol increased peak currents
evoked by 3 µM GABA with an EC50 of 190 µM and an
nH of 1.8. The extent of potentiation decreased with
increasing GABA concentrations and no potentiation was observed when
n-octanol was coapplied with 1000 µM GABA. One-minute preapplication of 1000 µM n-octanol slightly
potentiated 3 µM GABA-induced current, whereas it suppressed 300 µM
GABA-induced current to 16% of the control, suggesting that 84% of
the receptors underwent desensitization. Two models were used to
explain n-octanol agonistic and potentiating actions on
the
1
2
2S GABAA receptor: n-octanol
binds to multiple sites to exert multiple actions, or n-octanol acts as a partial agonist to manifest these
actions. The partial agonist model is unique because it is a simpler
model to explain n-octanol actions on the
GABAA receptor.
This article has been cited by other articles:
![]() |
J. Liang, E. Cagetti, R. W. Olsen, and I. Spigelman Altered Pharmacology of Synaptic and Extrasynaptic GABAA Receptors on CA1 Hippocampal Neurons Is Consistent with Subunit Changes in a Model of Alcohol Withdrawal and Dependence J. Pharmacol. Exp. Ther., September 1, 2004; 310(3): 1234 - 1245. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Rusch, H. Zhong, and S. A. Forman Gating Allosterism at a Single Class of Etomidate Sites on {alpha}1{beta}2{gamma}2L GABAA Receptors Accounts for Both Direct Activation and Agonist Modulation J. Biol. Chem., May 14, 2004; 279(20): 20982 - 20992. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zuo, J. Z. Yeh, and T. Narahashi Dual Action of n-Butanol on Neuronal Nicotinic alpha 4beta 2 Acetylcholine Receptors J. Pharmacol. Exp. Ther., March 1, 2003; 304(3): 1143 - 1152. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. E. Raines, R. J. Claycomb, and S. A. Forman Modulation of GABAA Receptor Function by Nonhalogenated Alkane Anesthetics: The Effects on Agonist Enhancement, Direct Activation, and Inhibition Anesth. Analg., January 1, 2003; 96(1): 112 - 118. [Abstract] [Full Text] [PDF] |
||||